58
Views
78
CrossRef citations to date
0
Altmetric
Review

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents

&
Pages 277-288 | Published online: 24 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Nicholas J. Donato & Luke F. Peterson. (2011) Chronic myeloid leukemia stem cells and developing therapies. Leukemia & Lymphoma 52:sup1, pages 60-80.
Read now
Alessio Giubellino, W Marston Linehan & Donald P Bottaro. (2009) Targeting the Met signaling pathway in renal cancer. Expert Review of Anticancer Therapy 9:6, pages 785-793.
Read now
Eleni M Karapanagiotou, Kostas Syrigos & Muhammad Wasif Saif. (2009) Heat shock protein inhibitors and vaccines as new agents in cancer treatment. Expert Opinion on Investigational Drugs 18:2, pages 161-174.
Read now
Valeria Milani, Monika Lorenz, Valeria Milani, Monika Lorenz, Marc Weinkauf, Malte Rieken, Alessandro Pastore, Martin Dreyling & Rolf Issels. (2009) Combination of hyperthermia and bortezomib results in additive killing in mantle cell lymphoma cells. International Journal of Hyperthermia 25:4, pages 262-272.
Read now
Len Neckers & Katharine Neckers. (2005) Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics – an update. Expert Opinion on Emerging Drugs 10:1, pages 137-149.
Read now

Articles from other publishers (73)

Han-Sol Kim, Chang-Min Kim, An-Na Jo & Joo-Eun Kim. (2022) Studies on Preformulation and Formulation of JIN-001 Liquisolid Tablet with Enhanced Solubility. Pharmaceuticals 15:4, pages 412.
Crossref
Xin Wang, Zhen-wu Du, Tian-min Xu, Xiao-jun Wang, Wei Li, Jia-li Gao, Jing Li & He Zhu. (2021) HIF-1α Is a Rational Target for Future Ovarian Cancer Therapies. Frontiers in Oncology 11.
Crossref
Beatriz C. D. de Oliveira, Mark E. Shiburah, Stephany C. Paiva, Marina R. Vieira, Edna Gicela O. Morea, Marcelo Santos da Silva, Cristiane de Santis Alves, Marcela Segatto, Fernanda Gutierrez-Rodrigues, Júlio C. Borges, Rodrigo T. Calado & Maria Isabel N. Cano. (2021) Possible Involvement of Hsp90 in the Regulation of Telomere Length and Telomerase Activity During the Leishmania amazonensis Developmental Cycle and Population Proliferation. Frontiers in Cell and Developmental Biology 9.
Crossref
Jyh-Cheng Chen, Jen-Chung Ko, Yong-Cing Taso, Hsiang-Hung Cheng, Tzu-Ying Chen, Ting-Chuan Yen & Yun-Wei Lin. (2021) Downregulation of Xeroderma Pigmentosum Complementation Group C Expression by 17-Allylamino-17-Demethoxygeldanamycin Enhances Bevacizumab-Induced Cytotoxicity in Human Lung Cancer Cells. Pharmacology 106:3-4, pages 154-168.
Crossref
Smriti Samanta, Suvranil Ghosh & Narayan Chandra Mandal. 2021. Endophytes. Endophytes 103 151 .
Nerea Allende-Vega & Martin Villalba. (2019) Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cells. Scientific Reports 9:1.
Crossref
Vadim Lincoln, Xin Tang, Mei Chen & Wei Li. 2019. Heat Shock Proteins in Signaling Pathways. Heat Shock Proteins in Signaling Pathways 289 315 .
Ninel Azoitei, Mathias Cobbaut, Alexander Becher, Johan Van Lint & Thomas Seufferlein. (2017) Protein kinase D2: a versatile player in cancer biology. Oncogene 37:10, pages 1263-1278.
Crossref
Hangming Dong, Lishan Luo, Mengchen Zou, Chaowen Huang, Xuan Wan, Yahui Hu, Yanqing Le, Haijin Zhao, Wei Li, Fei Zou & Shaoxi Cai. (2017) Blockade of extracellular heat shock protein 90α by 1G6-D7 attenuates pulmonary fibrosis through inhibiting ERK signaling. American Journal of Physiology-Lung Cellular and Molecular Physiology 313:6, pages L1006-L1015.
Crossref
Jeong Goo Kim, Sang Chul Lee, Ok-Hee Kim, Kee-Hwan Kim, Kyo Young Song, Sang Kuon Lee, Byung Jo Choi, Wonjun Jeong & Say-June Kim. (2017) HSP90 inhibitor 17-DMAG exerts anticancer effects against gastric cancer cells principally by altering oxidant-antioxidant balance. Oncotarget 8:34, pages 56473-56489.
Crossref
Wei Huang, Liqing Chen, Lin Kang, Mingji Jin, Ping Sun, Xin Xin, Zhonggao Gao & You Han Bae. (2017) Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs. Advanced Drug Delivery Reviews 115, pages 82-97.
Crossref
Diana Sofia Marques Nascimento, Catarina Soares Potes, Miguel Luz Soares, António Carlos Ferreira, Marzia Malcangio, José Manuel Castro-Lopes & Fani Lourença Moreira Neto. (2017) Drug-Induced HSP90 Inhibition Alleviates Pain in Monoarthritic Rats and Alters the Expression of New Putative Pain Players at the DRG. Molecular Neurobiology.
Crossref
Zhirui Zhang, Hong-Mei Li, Can Zhou, Qixiang Li, Linyan Ma, Zixuan Zhang, Yiming Sun, Lirong Wang, Xudong Zhang, Bing Zhu, Young-Soo Hong, Cheng-Zhu Wu & Hao Liu. (2016) Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells. Journal of Experimental & Clinical Cancer Research 35:1.
Crossref
Sujan Kumar Mondal, Sudhakar Jinka, Krishnendu Pal, Swetha Nelli, Shamit Kumar Dutta, Enfeng Wang, Ajaz Ahmad, Khalid M. AlKharfy, Debabrata Mukhopadhyay & Rajkumar Banerjee. (2016) Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors. Molecular Pharmaceutics 13:7, pages 2507-2523.
Crossref
A. A. Othman & Z. S. Shoheib. (2016) Detrimental effects of geldanamycin on adults and larvae of Trichinella spiralis . Helminthologia 53:2, pages 126-132.
Crossref
Stephanie Combs, Thomas Schmid, Peter Vaupel & Gabriele Multhoff. (2016) Stress Response Leading to Resistance in Glioblastoma—The Need for Innovative Radiotherapy (iRT) Concepts. Cancers 8:1, pages 15.
Crossref
HUI CHEN, LIANG-QING LI & DUN PAN. (2015) Geldanamycin induces apoptosis in human gastric carcinomas by affecting multiple oncogenic kinases that have synergic effects with TNF-related apoptosis-inducing ligand. Oncology Letters 10:6, pages 3732-3736.
Crossref
Bo-Kyung KimSo-Youn Woo. (2015) Heat Shock Protein 90 (HSP90) and Immune Regulation. Journal of Bacteriology and Virology 45:1, pages 62.
Crossref
JIANYUE WU, WEIMIN WANG, QIN SHAO, GUOMIN XIAO, JUN CHENG, YUNPENG YUAN & MEI ZHANG. (2014) Irradiation facilitates the inhibitory effect of the heat shock protein 90 inhibitor NVP-BEP800 on the proliferation of malignant glioblastoma cells through attenuation of the upregulation of heat shock protein 70. Experimental and Therapeutic Medicine 8:3, pages 893-898.
Crossref
Mohamed Hassan, Hidemichi Watari, Ali AbuAlmaaty, Yusuke Ohba & Noriaki Sakuragi. (2014) Apoptosis and Molecular Targeting Therapy in Cancer. BioMed Research International 2014, pages 1-23.
Crossref
Thulani H. Senanayake, Yaman Lu, Anna Bohling, Srikumar Raja, Hamid Band & Serguei V. Vinogradov. (2014) Encapsulation of Poorly Soluble Drugs in Polymer-Drug Conjugates: Effect of Dual-Drug Nanoformulations on Cancer Therapy. Pharmaceutical Research 31:6, pages 1605-1615.
Crossref
TAKASHI UI, KAZUE MORISHIMA, SHIN SAITO, YUJI SAKUMA, HIROFUMI FUJII, YOSHINORI HOSOYA, SHUMPEI ISHIKAWA, HIROYUKI ABURATANI, MASASHI FUKAYAMA, TOSHIRO NIKI & YOSHIKAZU YASUDA. (2014) The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway. Oncology Reports 31:2, pages 619-624.
Crossref
Ana B. OromendiaAngelika Amon. (2014) Aneuploidy: implications for protein homeostasis and disease. Disease Models & Mechanisms 7:1, pages 15-20.
Crossref
Uday Kumar Gupta, Sailendra Mahanta & Subhankar Paul. (2013) In silico design of small peptide-based Hsp90 inhibitor: A novel anticancer agent. Medical Hypotheses 81:5, pages 853-861.
Crossref
Xiaoping Sun, Jillian A. Bristol, Satoko Iwahori, Stacy R. Hagemeier, Qiao Meng, Elizabeth A. Barlow, Joyce D. Fingeroth, Vera L. Tarakanova, Robert F. Kalejta & Shannon C. Kenney. (2013) Hsp90 Inhibitor 17-DMAG Decreases Expression of Conserved Herpesvirus Protein Kinases and Reduces Virus Production in Epstein-Barr Virus-Infected Cells. Journal of Virology 87:18, pages 10126-10138.
Crossref
Sailendra Mahanta, Smita Pilla & Subhankar Paul. (2013) Design of novel Geldanamycin analogue hsp90 alpha-inhibitor in silico for breast cancer therapy. Medical Hypotheses 81:3, pages 463-469.
Crossref
Yuehong Cui, Weizhong Wu, Yuhong Zhou, Qian Xie, Tianshu Liu, Jianjun Jin & Kangda Liu. (2013) HSP27 expression levels are associated with the sensitivity of hepatocellular carcinoma cells to 17-allylamino-17-demethoxygeldanamycin. Future Oncology 9:3, pages 411-418.
Crossref
Bingbing Dai, Aihua Gong, Zhitao Jing, Kenneth D. Aldape, Shin-Hyuk Kang, Raymond Sawaya & Suyun Huang. (2013) Forkhead Box M1 Is Regulated by Heat Shock Factor 1 and Promotes Glioma Cells Survival under Heat Shock Stress. Journal of Biological Chemistry 288:3, pages 1634-1642.
Crossref
Wei Li, Fred Tsen, Divya Sahu, Ayesha Bhatia, Mei Chen, Gabriele Multhoff & David T. Woodley. 2013. 203 235 .
Bryan Newman, Yan Liu, Hsiu-Fang Lee, Duxin Sun & Yin Wang. (2012) HSP90 Inhibitor 17-AAG Selectively Eradicates Lymphoma Stem Cells. Cancer Research 72:17, pages 4551-4561.
Crossref
Manabu Tatokoro, Fumitaka Koga, Soichiro Yoshida, Satoru Kawakami, Yasuhisa Fujii, Len Neckers & Kazunori Kihara. (2011) Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer‐initiating cells. International Journal of Cancer 131:4, pages 987-996.
Crossref
Fabrizio Dal Piaz, Nicola Malafronte, Adriana Romano, Dario Gallotta, Maria Antonietta Belisario, Giuseppe Bifulco, Maria Josefine Gualtieri, Rokia Sanogo, Nunziatina De Tommasi & Claudio Pisano. (2012) Structural characterization of tetranortriterpenes from Pseudrocedrela kotschyi and Trichilia emetica and study of their activity towards the chaperone Hsp90. Phytochemistry 75, pages 78-89.
Crossref
Wei Li, Divya Sahu & Fred Tsen. (2012) Secreted heat shock protein-90 (Hsp90) in wound healing and cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1823:3, pages 730-741.
Crossref
Divya Sahu, Zhengwei Zhao, Fred Tsen, Chieh-Fang Cheng, Ryan Park, Alan J. Situ, Jinyao Dai, Ariana Eginli, Sharmineh Shams, Mei Chen, Tobias S. Ulmer, Peter Conti, David T. Woodley & Wei Li. (2012) A potentially common peptide target in secreted heat shock protein-90α for hypoxia-inducible factor-1α–positive tumors. Molecular Biology of the Cell 23:4, pages 602-613.
Crossref
Frank Wuest, Vincent Bouvet, BaoChan Mai & Paul LaPointe. (2012) Fluorine- and rhenium-containing geldanamycin derivatives as leads for the development of molecular probes for imaging Hsp90. Organic & Biomolecular Chemistry 10:33, pages 6724.
Crossref
Eleonora Di Zanni, Tiziana Bachetti, Sara Parodi, Paola Bocca, Ignazia Prigione, Simona Di Lascio, Diego Fornasari, Roberto Ravazzolo & Isabella Ceccherini. (2012) In vitro drug treatments reduce the deleterious effects of aggregates containing polyAla expanded PHOX2B proteins. Neurobiology of Disease 45:1, pages 508-518.
Crossref
Fabiola Cervantes-Gomez, Ramadevi Nimmanapalli & Varsha Gandhi. (2011) ATP Analog Enhances the Actions of a Heat Shock Protein 90 Inhibitor in Multiple Myeloma Cells. Journal of Pharmacology and Experimental Therapeutics 339:2, pages 545-554.
Crossref
Anne-Laure Rérole, Jessica Gobbo, Aurelie De Thonel, Elise Schmitt, Jean Paul Pais de Barros, Arlette Hammann, David Lanneau, Eric Fourmaux, Oleg Deminov, Olivier Micheau, Laurent Lagrost, Pierre Colas, Guido Kroemer & Carmen Garrido. (2011) Peptides and Aptamers Targeting HSP70: A Novel Approach for Anticancer Chemotherapy. Cancer Research 71:2, pages 484-495.
Crossref
Aftab Taiyab & Ch. Mohan Rao. (2011) HSP90 modulates actin dynamics: Inhibition of HSP90 leads to decreased cell motility and impairs invasion. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1813:1, pages 213-221.
Crossref
Chien-Yu Chen & Calvin Yu-Chian Chen. (2010) Insights into designing the dual-targeted HER2/HSP90 inhibitors. Journal of Molecular Graphics and Modelling 29:1, pages 21-31.
Crossref
Teneille Walker, Clint Mitchell, Margaret A. Park, Adly Yacoub, Mohamed Rahmani, Dieter Häussinger, Roland Reinehr, Christina Voelkel-Johnson, Paul B. Fisher, Steven Grant & Paul Dent. (2010) 17-Allylamino-17-Demethoxygeldanamycin and MEK1/2 Inhibitors Kill GI Tumor Cells via Ca2+-Dependent Suppression of GRP78/BiP and Induction of Ceramide and Reactive Oxygen Species. Molecular Cancer Therapeutics 9:5, pages 1378-1395.
Crossref
Xiaoping Sun, Elizabeth A. Barlow, Shidong Ma, Stacy R. Hagemeier, Sarah J. Duellman, Richard R. Burgess, Judy Tellam, Rajiv Khanna & Shannon C. Kenney. (2010) Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism. Proceedings of the National Academy of Sciences 107:7, pages 3146-3151.
Crossref
Isaac Yang, Shanna Fang & Andrew T. Parsa. (2010) Heat Shock Proteins in Glioblastomas. Neurosurgery Clinics of North America 21:1, pages 111-123.
Crossref
Yuxin Chen, Muzi Zhao, Saiqun Wang, Jie Chen, Yun Wang, Qinhong Cao, Wenbin Zhou, Jin Liu, Zhiyang Xu, Guoqing Tong & Jianmin Li. (2009) A novel role for DYX1C1, a chaperone protein for both Hsp70 and Hsp90, in breast cancer. Journal of Cancer Research and Clinical Oncology 135:9, pages 1265-1276.
Crossref
Aftab Taiyab, Amere S. Sreedhar & Ch. Mohan Rao. (2009) Hsp90 inhibitors, GA and 17AAG, lead to ER stress-induced apoptosis in rat histiocytoma. Biochemical Pharmacology 78:2, pages 142-152.
Crossref
Woncheol Kim, Dongho Lee, Seong Su Hong, Zhu Na, Jin Chul Shin, Su Heun Roh, Cheng-Zhu Wu, Oksik Choi, Kyeong Lee, Yue-Mao Shen, Sang-Gi Paik, Jung Joon Lee & Young-Soo Hong. (2009) Rational Biosynthetic Engineering for Optimization of Geldanamycin Analogues. ChemBioChem 10:7, pages 1243-1251.
Crossref
Fabiola Cervantes-Gomez, Ramadevi Nimmanapalli & Varsha Gandhi. (2009) Transcription Inhibition of Heat Shock Proteins: A Strategy for Combination of 17-Allylamino-17-Demethoxygeldanamycin and Actinomycin D. Cancer Research 69:9, pages 3947-3954.
Crossref
Rongsheng E. Wang, Jeffrey L.-F. Kao, Carolyn A. Hilliard, Raj K. Pandita, Joseph L. Roti Roti, Clayton R. Hunt & John-Stephen Taylor. (2009) Inhibition of Heat Shock Induction of Heat Shock Protein 70 and Enhancement of Heat Shock Protein 27 Phosphorylation by Quercetin Derivatives. Journal of Medicinal Chemistry 52:7, pages 1912-1921.
Crossref
Supriya Gaitonde, Surya K De, Marianna Tcherpakov, Antimone Dewing, Hongbin Yuan, Megan Riel-Mehan, Stan Krajewski, Gavin Robertson, Maurizio Pellecchia & Ze’ev Ronai. (2009) BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma. Pigment Cell & Melanoma Research 22:2, pages 187-195.
Crossref
Alberto Alcazar & Cristina Cid. (2009) High cytotoxic sensitivity of the oligodendrocyte precursor cells to HSP90 inhibitors in cell cultures. Experimental Neurology 216:2, pages 511-514.
Crossref
Barbara Dessars, Linda E. De Raeve, Renato Morandini, Anne Lefort, Hakim El Housni, Ghanem E. Ghanem, Benoît J. Van den Eynde, Wenbin Ma, Diane Roseeuw, Gilbert Vassart, Frédérick Libert & Pierre Heimann. (2009) Genotypic and Gene Expression Studies in Congenital Melanocytic Nevi: Insight into Initial Steps of Melanotumorigenesis. Journal of Investigative Dermatology 129:1, pages 139-147.
Crossref
Yi-Shan Lee, Kian-Huat Lim, Xing Guo, Yoshiharu Kawaguchi, Yasheng Gao, Tomasa Barrientos, Peter Ordentlich, Xiao-Fan Wang, Christopher M. Counter & Tso-Pang Yao. (2008) The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis. Cancer Research 68:18, pages 7561-7569.
Crossref
C Garcia-Echeverria & W R Sellers. (2008) Drug discovery approaches targeting the PI3K/Akt pathway in cancer. Oncogene 27:41, pages 5511-5526.
Crossref
Margaret A. Park, Guo Zhang, Clint Mitchell, Mohamed Rahmani, Hossein Hamed, Michael P. Hagan, Adly Yacoub, David T. Curiel, Paul B. Fisher, Steven Grant & Paul Dent. (2008) Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95 . Molecular Cancer Therapeutics 7:9, pages 2633-2648.
Crossref
R. H. Kim, R. Kim, W. Chen, S. Hu, K.-H. Shin, N.-H. Park & M. K. Kang. (2008) Association of hsp90 to the hTERT promoter is necessary for hTERT expression in human oral cancer cells. Carcinogenesis 29:12, pages 2425-2431.
Crossref
Christian N. Cunningham, Kristin A. Krukenberg & David A. Agard. (2008) Intra- and Intermonomer Interactions Are Required to Synergistically Facilitate ATP Hydrolysis in Hsp90. Journal of Biological Chemistry 283:30, pages 21170-21178.
Crossref
Derek S. Wheeler. (2008) Stress proteins and acute lung injury: Dreams can come true … eventually*. Critical Care Medicine 36:1, pages 360-362.
Crossref
Kristina M. Cook & Christopher J. Schofield. 2008. Angiogenesis. Angiogenesis 359 373 .
Govindarajulu Nagarajan, Cheng-Chin Kuo, Chi-Ming Liang, Chi-Min Chen & Shu-Mei Liang. (2007) Effects of CpG-B ODN on the protein expression profile of swine PBMC. Veterinary Research 38:6, pages 795-808.
Crossref
Jaroslaw Jozwiak, Wieslawa Grajkowska & Pawel Wlodarski. (2006) Pathogenesis of medulloblastoma and current treatment outlook. Medicinal Research Reviews 27:6, pages 869-890.
Crossref
Guillaume Lachapelle, Stefanie M. Radicioni, Adam R. Stankiewicz & Dick D. Mosser. (2007) Acute acidification or amiloride treatment suppresses the ability of Hsp70 to inhibit heat-induced apoptosis. Apoptosis 12:8, pages 1479-1488.
Crossref
Vassiliki Poulaki, Eirini Iliaki, Nicholas Mitsiades, Constantine S. Mitsiades, Yiannis N. Paulus, Deisy V. Bula, Evangelos S. Gragoudas & Joan W. Miller. (2007) Inhibition of Hsp90 attenuates inflammation in endotoxin‐induced uveitis. The FASEB Journal 21:9, pages 2113-2123.
Crossref
Fang Li, Pierre Sonveaux, Zahid N. Rabbani, Shanling Liu, Bin Yan, Qian Huang, Zeljko Vujaskovic, Mark W. Dewhirst & Chuan-Yuan Li. (2007) Regulation of HIF-1α Stability through S-Nitrosylation. Molecular Cell 26:1, pages 63-74.
Crossref
Sven A. Lang, Dagmar Klein, Christian Moser, Andreas Gaumann, Gabriel Glockzin, Marc H. Dahlke, Wolfgang Dietmaier, Ulrich Bolder, Hans J. Schlitt, Edward K. Geissler & Oliver Stoeltzing. (2007) Inhibition of heat shock protein 90 impairs epidermal growth factor–mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo . Molecular Cancer Therapeutics 6:3, pages 1123-1132.
Crossref
Carlos Garcia-Echeverria. 2007. Cancer. Cancer 169 206 .
Vincent P. Gullo, James McAlpine, Kin S. Lam, Dwight Baker & Frank Petersen. (2006) Drug discovery from natural products. Journal of Industrial Microbiology & Biotechnology 33:7, pages 523-531.
Crossref
Elise Schmitt, Loic Maingret, Pierre-Emmanuel Puig, Anne-Laure Rerole, François Ghiringhelli, Arlette Hammann, Eric Solary, Guido Kroemer & Carmen Garrido. (2006) Heat Shock Protein 70 Neutralization Exerts Potent Antitumor Effects in Animal Models of Colon Cancer and Melanoma. Cancer Research 66:8, pages 4191-4197.
Crossref
Tri K. Nguyen, Mohamed Rahmani, Ning Gao, Lora Kramer, Amie S. Corbin, Brian J. Druker, Paul Dent & Steven Grant. (2006) Synergistic Interactions between DMAG and Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitors in Bcr/abl+ Leukemia Cells Sensitive and Resistant to Imatinib Mesylate. Clinical Cancer Research 12:7, pages 2239-2247.
Crossref
Christopher Avila, Boris A. Kornilayev & Brian S.J. Blagg. (2006) Development and optimization of a useful assay for determining Hsp90’s inherent ATPase activity. Bioorganic & Medicinal Chemistry 14:4, pages 1134-1142.
Crossref
O. Stöltzing, S. A. Lang, D. Klein, U. Bolder, H. J. Schlitt & E. K. Geissler. 2006. Chirurgisches Forum 2006. Chirurgisches Forum 2006 45 47 .
Mark F. McCartyKeith I. Block. (2016) Multifocal Angiostatic Therapy: An Update. Integrative Cancer Therapies 4:4, pages 301-314.
Crossref
Edward G. Mimnaugh, Wanping Xu, Michele Vos, Xitong Yuan, Jennifer S. Isaacs, Kheem S. Bisht, David Gius & Len Neckers. (2004) Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. Molecular Cancer Therapeutics 3:5, pages 551-566.
Crossref
Bennett Kaufman, Orit Scharf, Jeffrey Arbeit, Margaret Ashcroft, J. Martin Brown, Richard K. Bruick, J. Donald Chapman, Sydney M. Evans, Amato J. Giaccia, Adrian L. Harris, Eric Huang, Randall Johnson, William KaelinJr.Jr., Cameron J. Koch, Patrick Maxwell, James Mitchell, Len Neckers, Garth Powis, Joseph Rajendran, Gregg L. Semenza, Jonathan Simons, Erik Storkebaum, Michael J. Welch, Murray Whitelaw, Giovanni Melillo & S. Percy Ivy. (2004) Proceedings of the Oxygen Homeostasis/Hypoxia Meeting. Cancer Research 64:9, pages 3350-3356.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.